User profiles for Despina G. Contopoulos-Ioannidis
Despina G. Contopoulos-Ioannidis, MDClinical Associate Professor, Dept. of Pediatrics, Stanford Univ. School of Medicine Verified email at stanford.edu Cited by 10179 |
Replication validity of genetic association studies
The rapid growth of human genetics creates countless opportunities for studies of disease
association. Given the number of potentially identifiable genetic markers and the multitude of …
association. Given the number of potentially identifiable genetic markers and the multitude of …
Comparison of evidence of treatment effects in randomized and nonrandomized studies
…, SI Kokori, MG Tektonidou, DG Contopoulos-Ioannidis… - Jama, 2001 - jamanetwork.com
ContextThere is substantial debate about whether the results of nonrandomized studies are
consistent with the results of randomized controlled trials on the same topic.ObjectivesTo …
consistent with the results of randomized controlled trials on the same topic.ObjectivesTo …
Genetic associations in large versus small studies: an empirical assessment
Background Advances in human genetics could help us to assess prognosis on an individual
basis and to optimise the management of complex diseases. However, different studies on …
basis and to optimise the management of complex diseases. However, different studies on …
Standard 6: age groups for pediatric trials
It has long been an axiom in clinical pediatrics that “children are not just little adults.” It has
also been recognized that there are many changes from birth through childhood and the …
also been recognized that there are many changes from birth through childhood and the …
Translation of highly promising basic science research into clinical applications.
DG Contopoulos-Ioannidis, E Ntzani… - The American journal of …, 2003 - europepmc.org
Purpose To evaluate the predictors of and time taken for the translation of highly promising
basic research into clinical experimentation and use. Methods We identified 101 articles, …
basic research into clinical experimentation and use. Methods We identified 101 articles, …
[HTML][HTML] Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic …
…, C Axfors, DG Contopoulos-Ioannidis - Environmental research, 2020 - Elsevier
Objective To provide estimates of the relative rate of COVID-19 death in people <65 years
old versus older individuals in the general population, the absolute risk of COVID-19 death at …
old versus older individuals in the general population, the absolute risk of COVID-19 death at …
Life cycle of translational research for medical interventions
DG Contopoulos-Ioannidis, GA Alexiou, TC Gouvias… - Science, 2008 - science.org
Recommendations for the Future Our analysis documents objectively show the long length
of time that passes between discovery and translation. As scientists, we should convey to our …
of time that passes between discovery and translation. As scientists, we should convey to our …
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
DG Contopoulos-Ioannidis, A Karvouni, I Kouri… - Bmj, 2009 - bmj.com
Objective To determine how often health surveys and quality of life evaluations reach different
conclusions from those of primary efficacy outcomes and whether discordant results make …
conclusions from those of primary efficacy outcomes and whether discordant results make …
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
The largest burden of COVID-19 is carried by the elderly, and persons living in nursing
homes are particularly vulnerable. However, 94% of the global population is younger than 70 …
homes are particularly vulnerable. However, 94% of the global population is younger than 70 …
Extended-interval aminoglycoside administration for children: a meta-analysis
DG Contopoulos-Ioannidis, ND Giotis, DV Baliatsa… - …, 2004 - publications.aap.org
Background. There has been a long-standing debate regarding whether aminoglycosides
should be administered on a multiple daily dosing (MDD) or once-daily dosing (ODD) …
should be administered on a multiple daily dosing (MDD) or once-daily dosing (ODD) …